Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Expression of Concern]
Hinz M, Stein A, Cole T. Clin Pharmacol Adv Appl. 2014;6:189–194. The Editor-in-Chief and Publisher of Clinical Pharmacology: Advances and Applications wish to issue an Expression of Concern for the published article. Concerns have been raised regarding the alleg...
Main Authors: | Hinz M, Stein A, Cole T |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-04-01
|
Series: | Clinical Pharmacology: Advances and Applications |
Subjects: | |
Online Access: | https://www.dovepress.com/eoc-parkinson39s-disease-carbidopa-nausea-and-dyskin-peer-reviewed-article-CPAA |
Similar Items
-
Parkinson’s Disease: Carbidopa, Nausea, and Dyskinesia [Retraction]
by: Hinz M, et al.
Published: (2021-03-01) -
The Parkinson’s Disease Death Rate: Carbidopa and Vitamin B6 [Expression of Concern]
by: Hinz M, et al.
Published: (2020-04-01) -
Association of Serum Vitamin B6 with All-Cause and Cause-Specific Mortality in a Prospective Study
by: Donghui Yang, et al.
Published: (2021-08-01) -
Associations of serum vitamin B6 status with the risks of cardiovascular, cancer, and all-cause mortality in the elderly
by: Pengxi Wang, et al.
Published: (2024-04-01) -
Parkinson's disease: carbidopa, nausea, and dyskinesia
by: Hinz M, et al.
Published: (2014-11-01)